• 1
    Polisson RP, Schoenberg OI, Fischman A, Rubin R, Simon LS, Rosenthal D, et al. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 81925.
  • 2
    Kraan MC, Versendaal H, Jonker M, Bresnihan B, Post WJ, 't Hart BA, et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 1998; 41: 14818.
  • 3
    Canat X, Guillaumont A, Poinot-Chazel C, Derocq JM, Carayon P, LeFur G, et al. Peripheral benzodiazepine receptor modulation with phagocyte differentiation. Biochem Pharmacol 1993; 46: 5514.
  • 4
    Banati RB, Newcombe J, Gunn RN, Cagrin A, Turkheimer F, Heppner F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000; 123: 232137.
  • 5
    Jones HA, Valind SO, Clark JC, Bolden GE, Krausz T, Schofield JB, et al. Kinetics of lung macrophages monitored in vivo following particulate challenge in rabbits. Toxicol Appl Pharmacol 2002; 183: 4654.
  • 6
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 7
    Elzinga EH, van der Laken CJ, Comans EF, Lammertsma AA, Dijkmans BA, Voskuyl AE. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis. Mol Imaging Biol 2007; 9: 35760.
  • 8
    Boellaard R, van Lingen A, van Balen SC, Hoving BG, Lammertsma AA. Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET. Eur J Nucl Med 2001; 28: 819.
  • 9
    Kropholler MA, Boellaard R, Schuurmaker A, van Berckel BN, Luurtsema G, Windhorst AD, et al. Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies. J Cereb Blood Flow Metab 2005; 25: 84251.
  • 10
    Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, Wijnholds J, et al. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res 2000; 60: 526977.
  • 11
    Dussosoy D, Carayon P, Feraut D, Belugou S, Combes T, Canat X, et al. Development of a monoclonal antibody to immuno-cytochemical analysis of the cellular localization of the peripheral benzodiazepine receptor. Cytometry 1996; 24: 3948.
  • 12
    Van Grieken NC, Weiss MM, Meijer GA, Boemena E, Lindeman J, Offerhaus GJ, et al. Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol 2001; 54: 639.
  • 13
    Beckers C, Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, et al. Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. J Nucl Med 2004; 45: 95664.